title: IGF-I treatment of patients with Laron syndrome suppresses serum thrombopoietin levels but does not affect serum erythropoietin.
authors.forename: Shevah
authors.initials: S
authors.lastname: Orit
authors.forename: Yacobovich
authors.initials: Y
authors.lastname: Joanne
authors.forename: Zoldan
authors.initials: Z
authors.lastname: Meira
authors.forename: Tamary
authors.initials: T
authors.lastname: Hannah
authors.forename: Laron
authors.initials: L
authors.lastname: Zvi
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D046150:Laron Syndrome / Q000097:blood* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D013926:Thrombopoietin / Q000097:blood*
chemical_list: D006133:Growth Substances; D004921:Erythropoietin; D007334:Insulin-Like Growth Factor I; D013926:Thrombopoietin